scispace - formally typeset
V

Vijay K. Chopra

Researcher at Max Super Speciality Hospital

Publications -  45
Citations -  7545

Vijay K. Chopra is an academic researcher from Max Super Speciality Hospital. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 16, co-authored 37 publications receiving 3350 citations. Previous affiliations of Vijay K. Chopra include Charité & Medanta.

Papers
More filters
Journal ArticleDOI

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

TL;DR: Among patients with heart failure and a reduced ejection fraction, the risk of worsening heart failure or death from cardiovascular causes was lower among those who received dapagliflozin than amongThose who received placebo, regardless of the presence or absence of diabetes.
Journal ArticleDOI

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

Matthew T. Roe, +1038 more
TL;DR: Among patients with unstable angina or myocardial infarction without ST-segment elevation, prasugrel did not significantly reduce the frequency of the primary end point, as compared with clopidogrel, and similar risks of bleeding were observed.
Journal ArticleDOI

Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

TL;DR: In this exploratory analysis of a randomized trial of patients with HFrEF, dapagliflozin compared with placebo, when added to recommended therapy, significantly reduced the risk of worsening heart failure or cardiovascular death independently of diabetes status.